Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERα in primary cultures of mouse mesencephalon

Mona Bains, Joanne C. Cousins, James Roberts

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Estrogen involvement in neuroprotection is now widely accepted, although the specific molecular and cellular mechanisms of estrogen action in neuroprotection remain unclear. This study examines estrogenic effects in a mixed population of cells in attempts to identify the contributing cells that result in estrogen-mediated neuroprotection. Utilizing primary mesencephalic neurons, we found expression of both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) with a predominance of ERα on both dopamine neurons and astrocytes. We also found that 17β-estradiol protects dopamine neurons from injury induced by the complex I inhibitor, 1-methyl-4-phenyl pyridinium (MPP+) in a time- and ER-dependent manner. At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the ER antagonist, ICI 182,780. Moreover, ERα mediated the protection afforded by estrogen since only the ERα agonist, HPTE, but not the ERβ agonist, DPN, protected against dopamine cell loss. Since glial cells were shown to express significant levels of ERα, we investigated a possible indirect mechanism of estrogen-mediated neuroprotection through glial cell interaction. Removal of glial cells from the cultures by application of the mitotic inhibitor, 5-fluoro-2′-deoxyuridine, significantly reduced the neuroprotective effects of estrogen. These data indicate that neuroprotection provided by estrogen against MPP+ toxicity is mediated by ERα and involves an interplay among at least two cell types.

Original languageEnglish (US)
Pages (from-to)767-776
Number of pages10
JournalExperimental Neurology
Volume204
Issue number2
DOIs
StatePublished - Apr 2007

Fingerprint

Estrogen Receptor alpha
Dopaminergic Neurons
Mesencephalon
Estrogens
Neuroglia
Neuroprotection
1-Methyl-4-phenylpyridinium
Estrogen Receptor beta
Neuroprotective Agents
Cell Communication
Astrocytes
NAD
Estradiol
Dopamine
Cell Culture Techniques
Neurons

Keywords

  • Astrocytes
  • Dopamine neuron
  • Estrogen
  • Estrogen receptor
  • Mesencephalon
  • MPP
  • Neuroprotection

ASJC Scopus subject areas

  • Neurology
  • Neuroscience(all)

Cite this

Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERα in primary cultures of mouse mesencephalon. / Bains, Mona; Cousins, Joanne C.; Roberts, James.

In: Experimental Neurology, Vol. 204, No. 2, 04.2007, p. 767-776.

Research output: Contribution to journalArticle

@article{f39c8cad004e4c279d20535fd8028aa0,
title = "Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERα in primary cultures of mouse mesencephalon",
abstract = "Estrogen involvement in neuroprotection is now widely accepted, although the specific molecular and cellular mechanisms of estrogen action in neuroprotection remain unclear. This study examines estrogenic effects in a mixed population of cells in attempts to identify the contributing cells that result in estrogen-mediated neuroprotection. Utilizing primary mesencephalic neurons, we found expression of both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) with a predominance of ERα on both dopamine neurons and astrocytes. We also found that 17β-estradiol protects dopamine neurons from injury induced by the complex I inhibitor, 1-methyl-4-phenyl pyridinium (MPP+) in a time- and ER-dependent manner. At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the ER antagonist, ICI 182,780. Moreover, ERα mediated the protection afforded by estrogen since only the ERα agonist, HPTE, but not the ERβ agonist, DPN, protected against dopamine cell loss. Since glial cells were shown to express significant levels of ERα, we investigated a possible indirect mechanism of estrogen-mediated neuroprotection through glial cell interaction. Removal of glial cells from the cultures by application of the mitotic inhibitor, 5-fluoro-2′-deoxyuridine, significantly reduced the neuroprotective effects of estrogen. These data indicate that neuroprotection provided by estrogen against MPP+ toxicity is mediated by ERα and involves an interplay among at least two cell types.",
keywords = "Astrocytes, Dopamine neuron, Estrogen, Estrogen receptor, Mesencephalon, MPP, Neuroprotection",
author = "Mona Bains and Cousins, {Joanne C.} and James Roberts",
year = "2007",
month = "4",
doi = "10.1016/j.expneurol.2007.01.020",
language = "English (US)",
volume = "204",
pages = "767--776",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERα in primary cultures of mouse mesencephalon

AU - Bains, Mona

AU - Cousins, Joanne C.

AU - Roberts, James

PY - 2007/4

Y1 - 2007/4

N2 - Estrogen involvement in neuroprotection is now widely accepted, although the specific molecular and cellular mechanisms of estrogen action in neuroprotection remain unclear. This study examines estrogenic effects in a mixed population of cells in attempts to identify the contributing cells that result in estrogen-mediated neuroprotection. Utilizing primary mesencephalic neurons, we found expression of both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) with a predominance of ERα on both dopamine neurons and astrocytes. We also found that 17β-estradiol protects dopamine neurons from injury induced by the complex I inhibitor, 1-methyl-4-phenyl pyridinium (MPP+) in a time- and ER-dependent manner. At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the ER antagonist, ICI 182,780. Moreover, ERα mediated the protection afforded by estrogen since only the ERα agonist, HPTE, but not the ERβ agonist, DPN, protected against dopamine cell loss. Since glial cells were shown to express significant levels of ERα, we investigated a possible indirect mechanism of estrogen-mediated neuroprotection through glial cell interaction. Removal of glial cells from the cultures by application of the mitotic inhibitor, 5-fluoro-2′-deoxyuridine, significantly reduced the neuroprotective effects of estrogen. These data indicate that neuroprotection provided by estrogen against MPP+ toxicity is mediated by ERα and involves an interplay among at least two cell types.

AB - Estrogen involvement in neuroprotection is now widely accepted, although the specific molecular and cellular mechanisms of estrogen action in neuroprotection remain unclear. This study examines estrogenic effects in a mixed population of cells in attempts to identify the contributing cells that result in estrogen-mediated neuroprotection. Utilizing primary mesencephalic neurons, we found expression of both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) with a predominance of ERα on both dopamine neurons and astrocytes. We also found that 17β-estradiol protects dopamine neurons from injury induced by the complex I inhibitor, 1-methyl-4-phenyl pyridinium (MPP+) in a time- and ER-dependent manner. At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the ER antagonist, ICI 182,780. Moreover, ERα mediated the protection afforded by estrogen since only the ERα agonist, HPTE, but not the ERβ agonist, DPN, protected against dopamine cell loss. Since glial cells were shown to express significant levels of ERα, we investigated a possible indirect mechanism of estrogen-mediated neuroprotection through glial cell interaction. Removal of glial cells from the cultures by application of the mitotic inhibitor, 5-fluoro-2′-deoxyuridine, significantly reduced the neuroprotective effects of estrogen. These data indicate that neuroprotection provided by estrogen against MPP+ toxicity is mediated by ERα and involves an interplay among at least two cell types.

KW - Astrocytes

KW - Dopamine neuron

KW - Estrogen

KW - Estrogen receptor

KW - Mesencephalon

KW - MPP

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=33947692720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947692720&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2007.01.020

DO - 10.1016/j.expneurol.2007.01.020

M3 - Article

VL - 204

SP - 767

EP - 776

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -